NIH-funded research R01 grant

Race-based stress reduction to improve well-being and inflammation in older African American women at risk for cardiometabolic disease

Official title: The Impact of a Race-Based Stress Reduction Intervention on Well-Being, Inflammation, and DNA methylation in Older African American Women at Risk for Cardiometabolic Disease

Funded at Loyola University Chicago · NIH-11299532 · Data updated 2026-11-12

A group-based 8-week program helps older African American women who are at risk for cardiometabolic disease manage stress from racism and sexism to improve well-being and reduce inflammation.

More Well-being research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionLoyola University Chicago
NIH-funded
Lab location1 site (Maywood, United States)
Project startApril 1, 2023
Project endJanuary 31, 2028
Funding year2026
Award (this year)$651,710
NIH project number5R01AG081251-04
Project IDNIH-11299532 on NIH RePORTER

Who could benefit from this research

Could help

Older African American women at risk for cardiometabolic disease who experience race-related stress and discrimination.

Less likely to help

Participants without significant race-related stress or who do not respond to behavioral interventions may see limited personal benefit.

What this research studies

This trial tests RiSE, a race-based stress reduction program combining cognitive-behavioral strategies with empowerment and racial identity work, delivered in group sessions over 8 weeks. Participants are older African American women at risk for cardiometabolic disease, and the study will measure well-being, inflammatory markers, and DNA methylation changes. The goal is to see whether reducing stress related to racism can lower inflammation and influence disease-related biological processes. The approach builds on preliminary work suggesting that stress reduction may benefit psychological health and biological risk factors tied to cardiometabolic disease.

Why it matters

Potential benefit: If successful, participants may experience improved well-being and potentially lower inflammation, which could reduce risk factors for cardiometabolic disease.

How similar studies have gone: Prior work suggests stress reduction can impact psychological distress and inflammation, but this specific race-based intervention is being tested for its effects on DNAm and CMD risk.

Where this research is happening

  • Loyola University Chicago
    Maywood, United States
    Active

Researchers

  • Principal investigator: Saban, Karen Lynn — Loyola University Chicago
  • Study coordinator: Saban, Karen Lynn

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.